These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


315 related items for PubMed ID: 27629742

  • 1. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
    Jiang C, Zhou L, Wang H, Zhang Q, Xu Y.
    Adv Clin Exp Med; 2016; 25(3):531-7. PubMed ID: 27629742
    [Abstract] [Full Text] [Related]

  • 2. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
    Zhou K, Zhao J, Xu H, Yan X, Liu W, Jiang X, Ren C.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun 28; 47(6):685-697. PubMed ID: 35837768
    [Abstract] [Full Text] [Related]

  • 3. Axl is a prognostic marker in oral squamous cell carcinoma.
    Lee CH, Yen CY, Liu SY, Chen CK, Chiang CF, Shiah SG, Chen PH, Shieh YS.
    Ann Surg Oncol; 2012 Jul 28; 19 Suppl 3():S500-8. PubMed ID: 21842265
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
    Wu Q, Xiang M, Wang K, Chen Z, Long L, Tao Y, Liang Y, Yan Y, Xiao Z, Qiu S, Yi B.
    Curr Cancer Drug Targets; 2020 Jul 28; 20(8):624-637. PubMed ID: 32329689
    [Abstract] [Full Text] [Related]

  • 7. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Xu YF, Ren XY, Li YQ, He QM, Tang XR, Sun Y, Shao JY, Jia WH, Kang TB, Zeng MS, Liu N, Ma J.
    BMC Cancer; 2015 Apr 30; 15():332. PubMed ID: 25925041
    [Abstract] [Full Text] [Related]

  • 8. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J, Zhang J, Xu M, Ke Z, Zhang W, Mai J.
    PLoS One; 2019 Apr 30; 14(4):e0215299. PubMed ID: 30973923
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma.
    Cao JY, Liu L, Chen SP, Zhang X, Mi YJ, Liu ZG, Li MZ, Zhang H, Qian CN, Shao JY, Fu LW, Xia YF, Zeng MS.
    Mol Cancer; 2010 Sep 09; 9():237. PubMed ID: 20828406
    [Abstract] [Full Text] [Related]

  • 10. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
    Tu L, Liu Z, He X, He Y, Yang H, Jiang Q, Xie S, Xiao G, Li X, Yao K, Fang W.
    Mol Cancer; 2010 Apr 16; 9():78. PubMed ID: 20398343
    [Abstract] [Full Text] [Related]

  • 11. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N, Wang L, Wang T, Li H.
    Tumour Biol; 2016 Jun 16; 37(6):8169-79. PubMed ID: 26715277
    [Abstract] [Full Text] [Related]

  • 12. Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival.
    Cui RX, Liu N, He QM, Li WF, Huang BJ, Sun Y, Tang LL, Chen M, Jiang N, Chen L, Yun JP, Zeng J, Guo Y, Wang HY, Ma J.
    BMC Cancer; 2012 Aug 29; 12():376. PubMed ID: 22931099
    [Abstract] [Full Text] [Related]

  • 13. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.
    Wang HY, Li YY, Shao Q, Hou JH, Wang F, Cai MB, Zeng YX, Shao JY.
    J Transl Med; 2012 Feb 09; 10():27. PubMed ID: 22321704
    [Abstract] [Full Text] [Related]

  • 14. CFTR is a potential marker for nasopharyngeal carcinoma prognosis and metastasis.
    Tu Z, Chen Q, Zhang JT, Jiang X, Xia Y, Chan HC.
    Oncotarget; 2016 Nov 22; 7(47):76955-76965. PubMed ID: 27769067
    [Abstract] [Full Text] [Related]

  • 15. Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients.
    Ishikawa M, Sonobe M, Nakayama E, Kobayashi M, Kikuchi R, Kitamura J, Imamura N, Date H.
    Ann Surg Oncol; 2013 Dec 22; 20 Suppl 3(Suppl 3):S467-76. PubMed ID: 23242819
    [Abstract] [Full Text] [Related]

  • 16. H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells.
    Zhang T, Lei F, Jiang T, Xie L, Huang P, Li P, Huang Y, Tang X, Gong J, Lin Y, Cheng A, Huang W.
    Curr Mol Pharmacol; 2019 Dec 22; 12(4):324-333. PubMed ID: 31677258
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.
    Dunne PD, McArt DG, Blayney JK, Kalimutho M, Greer S, Wang T, Srivastava S, Ong CW, Arthur K, Loughrey M, Redmond K, Longley DB, Salto-Tellez M, Johnston PG, Van Schaeybroeck S.
    Clin Cancer Res; 2014 Jan 01; 20(1):164-75. PubMed ID: 24170546
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.
    Liu SL, Lin HX, Qiu F, Zhang WJ, Niu CH, Wen W, Sun XQ, Ye LP, Wu XQ, Lin CY, Song LB, Guo L.
    PLoS One; 2017 Jan 01; 12(1):e0169280. PubMed ID: 28081138
    [Abstract] [Full Text] [Related]

  • 20. The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways.
    Luo DH, Chen QY, Liu H, Xu LH, Zhang HZ, Zhang L, Tang LQ, Mo HY, Huang PY, Guo X, Mai HQ.
    J Transl Med; 2013 Aug 29; 11():203. PubMed ID: 23987636
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.